logo
Orissa HC fixes July 17 date to review drainage works

Orissa HC fixes July 17 date to review drainage works

CUTTACK: The Orissa High Court has fixed July 17 to review the drainage upgrade work at the SCB Medical College and Hospital (SCB MCH), Acharya Harihar Post Graduate Institute for Cancer (AHPGIC) and Sardar Vallabhbhai Patel Post Graduate Institute of Pediatrics (Sishu Bhawan), in Cuttack.
The bench of Justice SK Sahoo and V Narasingh, which is dealing with PILs on civic issues in Cuttack city, fixed the date after taking on record a report submitted by CMC on rain preparedness for the ensuing monsoon at the three premier medical institutions following the HC's order.
According to the report, 80 per cent of the drain desilting work inside SCB MCH campus and AHPGIC completed and the rest will be finished by end of the month. It also stated that a high-power VOLVO pump bearing capacity of 24 HP has been installed for dewatering of storm water from the Sishu Bhawan campus. Another 10 HP pump will be provided, if required, at the time of heavy rains.
For construction of drainage facility inside Sishu Bhawan Rs 8.08 crore has already been approved by the Health & Family Welfare department. The internal drainage network will be completed by August 31, 2026, the report said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stress got you sucking? The rise of adult pacifiers
Stress got you sucking? The rise of adult pacifiers

India Today

timean hour ago

  • India Today

Stress got you sucking? The rise of adult pacifiers

Stress. Burnout. Sleepless nights. For many adults, these aren't just buzzwords, they're daily realities. But now, some are turning to a surprising tool for relief: adult you read that CRIBS TO CUBICLES: THE PACIFIER COMEBACKWhat was once a baby essential is now making waves in adult lives. Silicone pacifiers—designed for grown-ups—are selling out across e-commerce Priced anywhere between Rs 80 and Rs 5,000 (or $1 and $70), they've become a go-to for those seeking relief from anxiety, insomnia, or even nicotine ARE PEOPLE USING THEM?Fans say they help calm the nerves, ease panic attacks, and promote better sleep. Some even claim pacifiers reduce the urge to smoke or snack, offering a sense of comfort that's oddly have a name for it: regression. Under stress, our brains sometimes seek out familiar, childhood comforts. The act of sucking, as associated with early emotional security, can trigger a calming response in the brain.A VIRAL CRAZE IN CHINAThe trend has exploded in China. On platforms like Weibo, videos featuring adult pacifier use have amassed billions of views. On Taobao, sellers report shipping thousands every month. It's become more than a product—it's a social phenomenon, complete with fan communities and viral Is It Safe? Not are ringing the alarm. Long-term pacifier use can lead to jaw strain, misaligned teeth, bite issues, and even airway obstruction, especially if used during while pacifiers may offer quick comfort, experts caution: they don't actually solve stress, they just mask ALTERNATIVES THAT ACTUALLY HELPIf you're looking to cope with stress, here are safer, expert-recommended options:Chewing gum (satisfies oral fixation without dental risk)Stress balls or fidget toolsMindfulness and meditationJournaling or expressive writingProfessional therapy or counsellingTHE BOTTOM LINEAdult pacifiers may feel comforting at the moment, but they're no long-term solution. Tackling stress takes more than silicone. It means facing the root cause, not just soothing the before you click 'add to cart,' ask yourself: do I need a pacifier or a real pause?- Ends

Lupin launches Bosentan tablets for oral suspension in US market
Lupin launches Bosentan tablets for oral suspension in US market

Business Standard

time3 hours ago

  • Business Standard

Lupin launches Bosentan tablets for oral suspension in US market

Lupin announced the launch of Bosentan tablets for oral suspension, 32 mg in the United States, following approval received by its alliance partner, NATCO Pharma, from the US Food and Drug Administration (USFDA). According to an exchange filing, NATCO holds exclusive first-to-file status for the product and will benefit from 180-day generic drug exclusivity. The product is the bioequivalent to Tracleer Tablets for Oral Suspension, marketed by Actelion Pharmaceuticals US, Inc. Bosentan is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability. As per IQVIA MAT data for June 2025, Bosentan Tablets (RLD Tracleer) had estimated annual sales of approximately $10 million in the US market. Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Lupins consolidated net profit jumped 52.13% to Rs 1,219.03 crore on 11.78% increase in income from operations to Rs 6,163.75 crore in Q1 FY26 over Q1 FY25. Shares of Lupin declined 0.61% to Rs 1,956.50 on the BSE, while shares of Natco Pharma slipped 0.82% to Rs 885.95 on the BSE.

Biomedical waste treatment plant getting ready at Brahmapuram
Biomedical waste treatment plant getting ready at Brahmapuram

New Indian Express

time6 hours ago

  • New Indian Express

Biomedical waste treatment plant getting ready at Brahmapuram

KOCHI: Kochi corporation's new initiative to address the growing problem of sanitary and special care waste disposal -- biomedical waste treatment plant -- is expected to be commissioned in September. The Rs 3.45-crore plant, a first-of-its-kind initiative by a local body in the state, is nearing completion at the Brahmapuram waste dumping site. All biomedical waste, except hospital-generated waste falling under the hazardous category, can be incinerated at the new plant. On an average, around 100 tonnes of sanitary and special care waste are generated every month in Kochi, which includes sanitary napkins, diapers, and medical waste collected by government-approved agencies. 'Two government-approved agencies have currently collected more than two tonnes of sanitary and special care waste. This is being transported to the Kerala Enviro Infrastructure Ltd (KEIL) unit in Ambalamedu. Once the new plant is commissioned, we will be able to treat and dispose of the biomedical waste at Brahmapuram,' a senior health official with the Kochi corporation told TNIE.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store